European Commission logo
European Commission

Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections

Pays a fixed EUR 15 million grant to run multicentre clinical trials proving bacteriophage therapy works against antibiotic-resistant infections.

ClosedEuropean CommissionUnited States

Testing safety and efficacy of phage therapy for the treatment of antibiotic-resistant bacterial infections is a European Commission grant funding multicentre, multinational randomised controlled clinical trials of bacteriophage therapy against bacterial infections that don't respond to conventional antibiotics. Proposals must include a sound clinical trial protocol, a delivery date for regulatory…

This call funds multicentre, multinational randomised controlled clinical trials testing bacteriophage (phage) therapy β€” personalised phage preparations or ready-to-use phage cocktails β€” as a stand-alone or combination treatment for bacterial infections that don't respond to conventional antibiotics. It's open to any pathogen causing difficult-to-treat infections from antimicrobial resistance or biofilms, any clinical indication, and any route of administration.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.No fixed schedule
Next deadlineiThe next date applications are due. Rolling means you can apply any time.-
Decision timeiTypical time from the deadline to the funder's decision.-
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.€45M

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides β†’

More from European Commission

All grants from this funder β†’
European Commission logo
Open

Digital Europe Programme

πŸ‡ͺπŸ‡ΊEuropean Commission Β· European Union

Funds Europe-wide digital capability development in AI, cybersecurity, semiconductors, hardware, and IoT.

AICybersecurity+3
Oct'26
European Commission logo
Open

Crime prevention approaches, online and off-line, tackling the nexus between addictions and crime

πŸ‡ͺπŸ‡ΊEuropean Commission Β· European Union

Funds research and pilot collaboration between police authorities and civil-society groups to prevent addiction-linked crime across the EU.

€3MNov'26
European Commission logo
Open

Horizon Border Security: Accessible Travel Facilitation

πŸ‡ͺπŸ‡ΊEuropean Commission Β· European Union

Funds two €4M border-crossing tech projects, run with Border or Coast Guard Authorities, built for travelers with disabilities or low digital skills.

DefenseAI
€4MNov'26
European Commission logo
Open

Horizon Border Security: Age Assessment Reliability

πŸ‡ͺπŸ‡ΊEuropean Commission Β· European Union

Funds a €1.33M project, run with border and coast guard authorities, that compares how reliable different ways of estimating a young migrant's age really are.

Defense
€1.3MNov'26
European Commission logo
Open

Horizon Border Security: Surveillance & Drone Detection

πŸ‡ͺπŸ‡ΊEuropean Commission Β· European Union

Funds two €6M projects that build border detection and surveillance tech, run jointly with national Border and Coast Guard authorities.

DefenseIoT & Edge
€6MNov'26
European Commission logo
Open

Horizon Civil Security: Bioterrorism Prevention

πŸ‡ͺπŸ‡ΊEuropean Commission Β· European Union

Funds a €3M project that reviews how synthetic biology could be misused for bioterrorism and pinpoints where monitoring and regulation fall short.

Synthetic BiologyDefense
€3MNov'26
Cystic Fibrosis Foundation logo
Open

CFF Mission Ventures Industry Investment

πŸ‡ΊπŸ‡ΈCFF Β· United States

Offers startup and industry teams with commercialization support for CFF Mission Ventures Industry Investment in biotechnology, medical technology, and synthetic biology.

BiotechMedtech+1
$5M – $25M
US Department of Health and Human Services logo
Open

Title X Family Planning Services Grants

πŸ‡ΊπŸ‡ΈHHS Β· United States

Supports family planning service providers across United States jurisdictions with grants that strengthen sexual health prevention, testing, counseling, and care.

MedtechBiotech
$200K – $22MJan'27
National Institutes of Health logo
Open

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy

πŸ‡ΊπŸ‡ΈNIH Β· United States

Funds work combining imaging with liquid biopsy during cancer treatment, to see sooner whether it is working or resistance is emerging.

MedtechBiotech
$500KJan'28
National Institutes of Health logo
Open

NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

πŸ‡ΊπŸ‡ΈNIH Β· United States

Funds an investigator's own phase I trial in heart, lung, blood or sleep disease β€” with every regulatory approval already in hand at award.

BiotechMedtech
$1.5MJan'27
National Institutes of Health logo
Open

Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions

πŸ‡ΊπŸ‡ΈNIH Β· United States

Funds small clinical-trial research at undergraduate-focused colleges that get under $6 million a year from NIH.

BiotechMedtech
$375KJan'27
National Institute on Alcohol Abuse and Alcoholism logo
Open

Prevention and Intervention Approaches for FASD (R34)

πŸ‡ΊπŸ‡ΈNIAAA Β· United States

Supports FASD prevention and intervention planning studies to establish feasibility and practical research direction.

MedtechBiotech
$450KJan'27